Welcome to CVFS-SCAN

Chitwan Valley Family Study – Study on Cognition and Aging in Nepal

The CVFS-SCAN study aims to lay the foundation for a sustainable, population-based research program focused on Alzheimer's disease and related dementias (ADRD) and broader age-related health challenges in Nepal.

As Nepal's population ages, more adults are living longer, but with increased risk of cognitive decline, chronic conditions, and disability. Despite the rising burden of ADRD, there is currently limited national capacity to monitor, prevent, or manage these conditions, due to the absence of systematic data and a specialized research infrastructure.

To address this urgent gap, CVFS-SCAN leverages the longstanding Chitwan Valley Family Study (CVFS), a respected and nationally recognized longitudinal study that began in 1995. With decades of detailed family, community , and life history data, CVFS provides a unique foundation for launching a new wave of dementia-focused research tailored to Nepal's specific historical, social, and demographic context.

Overall Goal

To develop a foundation for sustained, high-quality, population-based research into ADRD and other age-related chronic conditions in Nepal.

Objectives

  • Build capacity in Nepal for the conduct of systematic, population-based research on Alzheimer’s disease and related dementias.
  • Develop and implement a new, longitudinal cohort study of ADRD and related aging-associated health conditions among older adults in Nepal.

Specific Aims

  1. Build research capacity for the conduct of studies of ADRD and other aging-related changes in health. Specific capacity-building activities focus on:
    • The design and administration of culturally appropriate cognitive assessments to identify ADRD in the general population.
    • Building expertise in statistical methods for the analysis of longitudinal data from complex surveys.
  2. Design and conduct a population-based study of ADRD and other age-associated conditions among 4,000 adults aged 50+ and their informants, including a baseline interview and a follow-up interview two years later.
  3. Estimate the prevalence and incidence of ADRD and its primary clinical feature, cognitive impairment, and test associations between primary risk factors and ADRD/cognitive impairment and other relevant outcomes (e.g., disability, caregiving needs).
    • In these analyses, we will test the specific hypotheses that longer duration of international labor migration and exposure to armed conflict are associated with an increased risk of ADRD and cognitive impairment.

Timeline and Current Status

2022
  • The study began in 2022 and is projected to conclude by 2027.
  • Ethical approval from NHRC, Nepal received on December 20, 2022 (NHRC Ref No: 1334).
  • Adaptation and translation of survey instruments and cognitive test battery development process started.
2023
  • Iterative translation and expert review of survey instruments.
  • Focus Group Discussion on translation of study materials.
  • Trainers training on cognitive interviewing technique.
  • Piloting of venous blood collection, extraction, storage, and shipping.
2024
  • Cognitive interviews conducted with diverse respondents aged 50+ from various backgrounds to assess understanding of study questions and identify areas of confusion for further refinement.
  • Interviewer hiring and organized trainings (GIT, NHCAP, SST trainings and data analysis training).
  • Pre-testing of the survey instruments.
2025 Current Year
  • Refinement and finalization of survey instruments based on pre-test results.
  • Organized GIT, NHCAP, SST, and blood sample collection trainings for the final data collection.
  • Final data collection launched on February 20, 2025.
2026–27
  • Second wave of data collection.
  • Follow-up assessments that focus on assessing change in cognitive outcomes.
  • Analyze longitudinal patterns of cognitive decline and onset of ADRD.

Our Collaborators

Michigan University
Georgetown University
ISER-N